Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.966 on 22-07-2026 at 12:18:06
Change $-0.004 -0.41%
Buy $0.97
Sell $0.966
Last Trade: Sell 10.00 at $0.966
Day's Volume: 2,039,317
Last Close: $0.97
Open: $0.97
ISIN: GB00BDGKMY29
Day's Range $0.964 - $0.97
52wk Range: $0.858 - $1.00
Market Capitalisation: $1.08b
VWAP: $0.966801
Shares in Issue: 1.12b

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 10 $0.966 Automatic Execution
13:18:06 - 22-Jul-26
Sell* 11 $0.966 Automatic Execution
13:15:07 - 22-Jul-26
Sell* 12 $0.966 Automatic Execution
13:12:09 - 22-Jul-26
Unknown* 2,960 $0.968 SI Trade
13:10:40 - 22-Jul-26
Sell* 11 $0.966 Automatic Execution
13:09:11 - 22-Jul-26
Sell* 11 $0.966 Automatic Execution
13:06:12 - 22-Jul-26
Sell* 11 $0.966 Automatic Execution
13:03:14 - 22-Jul-26
Sell* 3,347 $0.966 Automatic Execution
13:01:12 - 22-Jul-26
Sell* 440 $0.966 SI Trade
13:00:16 - 22-Jul-26
Sell* 12 $0.966 Automatic Execution
13:00:15 - 22-Jul-26
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
21st Jul 2026 (Tue) 0.968 0.972 0.964 0.97 800,260
20th Jul 2026 (Mon) 0.96 0.968 0.96 0.966 1,393,241
17th Jul 2026 (Fri) 0.962 0.964 0.96 0.96 764,638
16th Jul 2026 (Thu) 0.964 0.964 0.96 0.964 790,410
15th Jul 2026 (Wed) 0.958 0.962 0.958 0.96 2,613,018
14th Jul 2026 (Tue) 0.954 0.96 0.954 0.96 488,883
13th Jul 2026 (Mon) 0.964 0.964 0.956 0.962 1,021,081
10th Jul 2026 (Fri) 0.956 0.96 0.954 0.96 953,711
9th Jul 2026 (Thu) 0.956 0.96 0.954 0.954 315,038
8th Jul 2026 (Wed) 0.962 0.962 0.958 0.96 987,553
7th Jul 2026 (Tue) 0.966 0.966 0.958 0.96 1,007,413
6th Jul 2026 (Mon) 0.96 0.966 0.956 0.962 1,360,360
3rd Jul 2026 (Fri) 0.954 0.964 0.954 0.958 1,170,142
2nd Jul 2026 (Thu) 0.944 0.96 0.94 0.96 3,953,712
1st Jul 2026 (Wed) 0.96 0.966 0.956 0.96 990,238
30th Jun 2026 (Tue) 0.962 0.962 0.954 0.954 532,962
29th Jun 2026 (Mon) 0.966 0.966 0.956 0.96 1,226,057
26th Jun 2026 (Fri) 0.958 0.962 0.956 0.962 1,196,842
25th Jun 2026 (Thu) 0.96 0.964 0.96 0.964 698,092
24th Jun 2026 (Wed) 0.96 0.964 0.958 0.96 1,244,201
23rd Jun 2026 (Tue) 0.946 0.964 0.946 0.964 1,050,387
22nd Jun 2026 (Mon) 0.944 0.96 0.944 0.954 409,439
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
15th Jul 2026 7:00 am RNS NEW INVESTMENT IN KESTRA MEDICAL
14th Jul 2026 7:00 am RNS UPDATE ON ARCHIMED ESPERION ACQUISITION
19th Jun 2026 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
19th Jun 2026 10:47 am RNS Dividend Declaration
17th Jun 2026 5:46 pm RNS Result of AGM
9th Jun 2026 8:00 am RNS NEW INVESTMENT
3rd Jun 2026 11:40 am RNS New Investment
1st Jun 2026 4:51 pm RNS Director/PDMR Shareholding
1st Jun 2026 1:39 pm RNS Total Voting Rights
26th May 2026 6:15 pm RNS Transaction in Own Shares
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

UK shareholder meetings calendar - next 7 days

10th Jun 2026 13:22

Read More

BioPharma Credit commits up to CHF75 million to Idorsia loan

9th Jun 2026 11:08

(Alliance News) - BioPharma Credit PLC on Tuesday announced a new investment of up to CHF75 million, around USD94.2 million, in Allschwil, Switzerland-based Idorsia Pharmaceuticals Ltd as part of a larger CHF250 million senior secured financing package. Read More

TRADING UPDATES: Afentra and Portmeirion intend to launch fundraises

3rd Jun 2026 21:43

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

UK dividends calendar - next 7 days

22nd May 2026 14:22

Read More

IN BRIEF: BioPharma Credit notes full prepayment of loan facility

6th May 2026 11:59

BioPharma Credit PLC - London-based closed-ended investment company focused on the life sciences industry - Regarding Alphatec Holdings Inc, BioPharma Credit notes the prepayment in full of its USD200 million senior secured loan facility, of which it had an investment of USD35 million. BioPharma Credit says it earned a 14.91% gross internal rate of return and an 11.93% net internal rate of return on its Alphatec Holdings investment. Alphatec on Tuesday announced it entered into a new credit facility, including a USD125 million revolving credit facility and a USD175 million term loan A. Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value10,733.23
Change147.32

Login to your account

Forgot Password?

Not Registered